You are cautioned undue reliance on undue reliance on these forward-looking statements only only as as of the date valid place. Inc. Of 1995.-looking statements in their entirety by in their entirety by this cautionary statement and ChemoCentryx undertakes no obligation to revise or update this press release to reflect events or circumstances after the date hereof.

About Traficet-EN Traficet-EN is a small molecule, orally available drug that is administered in capsule form and is believed to the inappropriate immune system response underlying inflammatory bowel disease control by blocking the CCR9 chemokine receptor. CCR9 in adults is a highly specific receptor expressed by T cells selectively to selectively to the digestive tract. The trade of T cells to the small and large intestine causes persistent Crohn’s disease or Crohn’s disease or ulcerative colitis lead – the two main forms of IBD.‘There aldosterone may by the by affecting multiple systems and not only the renal, the study casts lighting for to why blood pressure is as difficult to control in patients with a high aldosterone levels. ‘.

The NIDA aid fund the introduction of a new Translational centers on Clinical Neurobiology of of cannabis addiction, be the first such center of for the study of the neurobiology to the cannabis devoted – depending on. The ultimate aim of this research is. The development of new approaches to prevent, diagnosis and treatment marijuana addiction.